E
ERAS icon

Ergoteles’s Erasca ERAS Stock Holding History

Ergoteles’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-13,338
Closed -$208K – 1334
2021
Q4 		$208K Buy
+13,338
New +$228K 0.01% 1011

Other funds holding ERAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
AEPBI
AH Equity Partners Bio II Menlo Park, California $144M AUM 54.61% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Ergoteles's ERAS Position: Q1 2022 in Review

Ergoteles sold out of Erasca (ERAS) in Q1 2022, closing a stake of 13,338 shares — an estimated $208K sold.

Ergoteles first reported a position in ERAS in Q4 2021 and held it in 1 quarter. The position peaked at $208K in Q4 2021. 82 funds tracked by Wall St. Rank hold ERAS as of Q1 2022.

  • Ergoteles reported no remaining Erasca position as of Q1 2022 after selling out during the quarter.
  • Ergoteles sold 13,338 Erasca shares in Q1 2022, an estimated $208K.
  • Ergoteles first reported a position in Erasca in Q4 2021 and held it in 1 quarter.
  • Ergoteles's Erasca position peaked at $208K in Q4 2021.
  • 82 funds tracked by Wall St. Rank held Erasca as of Q1 2022.

Based on Ergoteles's 13F filing for Q1 2022, filed 13 May 2022.